Münevver Demir

机构：Humboldt-Universität zu Berlin, Charité - Universitätsmedizin Berlin · ORCID：0000-0002-7050-797X

发表论文 207 篇 · 总被引 4508 次 · h-index 34

代表论文

• Safety and efficacy of elafibranor in primary sclerosing cholangitis: The ELMWOOD phase II randomized-controlled trial (2025 · Journal of Hepatology · 被引 23)
• Limitations of Guideline‐Recommended Risk Stratification in Identifying MASLD Patients for Novel Drug Treatments (2025 · Liver International · 被引 9)
• Soluble Urokinase Plasminogen Activator Receptor Predicts Survival and Hepatic Decompensation in Advanced Hepatocellular Carcinoma (2025 · Liver International · 被引 8)
• Evaluating Resmetirom Eligibility Among Patients with MASH: Insights from the German Steatotic Liver Disease-Registry (2025 · Zeitschrift für Gastroenterologie · 被引 6)
• Impact of Handling Perception and Language Barriers on Virologic Response to Daily Subcutaneous Bulevirtide in Hepatitis D (2025 · Liver International · 被引 3)
• Therapeutic plasma exchange in amatoxin associated acute liver failure–results from the multi-center Amanita-PEX study (2025 · Critical Care · 被引 2)